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a b s t r a c t 
We propose a mathematical model for the onset and progression of Alzheimer’s disease based on transport and 
diffusion equations. We treat brain neurons as a continuous medium and structure them by their degree of mal- 
functioning. Three different mechanisms are assumed to be relevant for the temporal evolution of the disease: i) 
diffusion and agglomeration of soluble Amyloid beta, ii) effects of phosphorylated tau protein and iii) neuron-to- 
neuron prion-like transmission of the disease. We model these processes by a system of Smoluchowski equations 
for the Amyloid beta concentration, an evolution equation for the dynamics of tau protein and a kinetic-type 
transport equation for the distribution function of the degree of malfunctioning of neurons. The latter equation 
contains an integral term describing the random onset of the disease as a jump process localized in particularly 
sensitive areas of the brain. We are particularly interested in investigating the effects of the synergistic interplay 
of Amyloid beta and tau on the dynamics of Alzheimer’s disease. The output of our numerical simulations, al- 
though in 2D with an over-simplified geometry, is in good qualitative agreement with clinical findings concerning 
both the disease distribution in the brain, which varies from early to advanced stages, and the effects of tau on 













































Alzheimer’s disease (AD) is a progressive neurodegenerative disease
haracterized by the formation of insoluble protein aggregates and loss
f neurons and synapses. This causes a progressive decline in memory
nd other cognitive functions, and ultimately dementia. The processes
eading to protein aggregation and neurodegeneration are only partially
nderstood [11] . AD was first described in 1907 by Alois Alzheimer
ho reported two pathological hallmarks in the brain: amyloid plaques
n the extracellular medium and neurofibrillary tangles (NFTs). It was
ot until eight decades later that the major proteinaceous components
f these lesions were identified. Amyloid plaques consist primarily of
ggregates of Amyloid beta peptides (A 𝛽) [20] , whereas the main con-
tituent of neurofibrillary tangles is tau protein ( 𝜏) in a hyperphospho-
ylated form [24] . Up to now, A 𝛽 and 𝜏 remain the major therapeutic
argets for the treatment of AD. According to the 2019 World Alzheimer
eport, it is estimated that there are presently 50 million people living
ith AD and related disorders, and this figure is expected to increase to
52 million by 2050 due to an increasingly aged population. As current
reatments are purely for modest symptomatic relief, there is an urgent∗ Corresponding author. 
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 http://creativecommons.org/licenses/by-nc-nd/4.0/ ) eed for reliable and efficient computational models able to provide in-
ights for effective therapies for the disease. 
How A 𝛽 and 𝜏 interact to cause neurodegeneration remains a major
nowledge gap in the field. There is substantial evidence that oligomeric
 𝛽 has a role in synapse degeneration, both in computational models
nd in human postmortem tissues, and that pathological forms of 𝜏 are
ufficient to induce synapse loss and circuit dysfunction in models of
auopathy. In this context Jack e.a [29] . discuss a set of major biomarkers
or AD and conclude that measures of both A 𝛽 and 𝜏 (both deposited and
n CSF) are necessary to ascertain important features of AD pathology;
his view stands in opposition to an amyloid-centric (or even taucen-
ric) hypothesis. There is also increasing evidence that the progression
f AD dementia is driven by the synergistic interaction between A 𝛽 and
, which is responsible for synaptic dysfunction, neurofibrillary tangle
ediated neuron loss, and behavioral deficits [14,34,41] . For example,
n [30] the authors discuss possible relations between A 𝛽 aggregation,
au pathology and tau cell-to-cell transfer in AD; on the one hand the
isease severity seems to correlate better with the severity of tau pathol-
gy than with that of A 𝛽 pathology, on the other hand A 𝛽 can enhance
he formation of tau pathology [27,32] and cell-to-cell transfer of 𝜏 [42] .cember 2020 
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t  Based on experiments with transgenic mice, in [27] the authors dis-
uss several possible models for the interaction between A 𝛽 and 𝜏 as well
s for their toxic effects. Basically, they discuss three different models:
) A 𝛽 drives 𝜏 pathology by causing hyperphosphorylation of 𝜏, which in
urn mediates toxicity in neurons; b) 𝜏 mediates A 𝛽 toxicity and hence,
 𝛽 toxicity is critically dependent on the presence of 𝜏 for example, in
he dendrite; c) A 𝛽 and 𝜏 target cellular processed or organelles syner-
istically, thereby possibly amplifying each others toxic effects. 
.1. The microtubule-associated 𝛕
The 𝜏 protein is a microtubule-associated protein (MAP) that is en-
oded by the MAPT gene. The protein contains an amino-terminal pro-
ection domain, a proline-rich region, a carboxy-terminal domain with
icrotubule-binding repeats, and a short tail sequence. Tau has been
eported to interact with many proteins, serving important scaffolding
unctions [16]. In particular, it acts in concert with heterodimers of 𝛼-
nd 𝛽-tubulin to assemble microtubules and regulate motor-driven ax-
nal transport. In the adult human brain 𝜏 occurs in six isoforms, with
ither three or four microtubule-binding domains, which result from al-
ernative splicing of exons 2, 3 and 10 of the MAPT gene. Tau is enriched
nside the neurons. Tau is most naturally located in the axons of neu-
ons, but is present in dendrites in smaller amounts. The distinguishing
actor that separates normal 𝜏 from that observed in patients with AD
s its hyperphosphorylation. The longest isoforms of human 𝜏 contain
0 serine and threonine residues and five tyrosine residues, all of which
an potentially be phosphorylated. In the disease state, the amount of
yperphosphorylated 𝜏 is at least three times higher than that in the
ormal brain [26] . It is not entirely clear, however, whether phospho-
ylation of 𝜏 at specific sites results in the pathogenicity observed in AD
r whether it only requires a certain overall level of phosphorylation.
evertheless, hyperphosphorylation of 𝜏 negatively regulates the bind-
ng of 𝜏 to microtubules, which compromises microtubule stabilization
nd axonal transport. Hyperphosphorylation also increases the capac-
ty of 𝜏 to self-assemble and form aggregates from oligomers to fibrils,
ventually leading to its deposition as NFTs. In addition, hyperphospho-
ylated 𝜏 has been shown to interfere with neuronal functions, causing
educed mitochondrial respiration, altered mitochondrial dynamics and
mpaired axonal transport. Tau pathology progresses through distinct
eural networks, and in AD NFTs are prominent in the cortex in an
arly stage, and later appear in anatomically connected brain regions. 
Furthermore, it has been demonstrated that excess 𝜏 aggregates can
e released into the extracellular medium, to be internalized by sur-
ounding neurons and induce the fibrillization of endogenous 𝜏; this
uggests a role for 𝜏 seeding in neurodegeneration [22] . 
.2. Amyloid 𝛃
Sequential cleavage of the amyloid precursor protein (APP) by 𝛽- and
-secretase results in the generation of a range of A 𝛽 peptides from 39
o 43 amino acid residues in length, although A 𝛽40 and A 𝛽42 are the pre-
ominant species in vivo. The hydrophobic nature of the peptides, par-
icularly A 𝛽42 and A 𝛽43 , allows them to self-aggregate and form a myriad
f species from dimers to small molecular weight oligomers, to protofib-
ils, to fibrils, ultimately leading to their deposition as amyloid plaques.
urthermore, A 𝛽 peptides can also undergo pyroglutamate modification
t amino acid position three (A 𝛽3(pE)); this increases the stability, ag-
regation propensity and neurotoxicity compared to full-length, unmod-
fied A 𝛽. The mechanism by which excessive A 𝛽 accumulation occurs in
poradic AD remains unclear. Reduced A 𝛽 clearance or small increases
n A 𝛽 production over a long period of time are potential mechanisms
hat result in the accumulation of A 𝛽 in the brain. The role of reduced
 𝛽 clearance is an important research topic which is widely discussed
n the literature [25,50] . The papers [9,33,36] review various aspects
f increased A 𝛽 production, a potentially intricate and complex process.
amaged neurons could cause increased production but 𝜏 may play a2 ole in this process. If for example some A 𝛽 aggregates are formed and
hosphorylated 𝜏 seeds are present in a proximal neuron, the aggregates
ay cause 𝜏 to relocate in the soma-dendritic compartment, where the
rrant 𝜏 can cause toxic effects to the neuron itself. 
As we already pointed out, there are several possible models for the
nteraction between A 𝛽 and 𝜏. Some of them are presented in [27] In
articular, the authors present what they call 𝜏-axis hypothesis of AD:
rogressively increasing levels of dendritic 𝜏 make neurons vulnerable
o A 𝛽. 
There is considerable debate regarding which of the A 𝛽 species
s most neurotoxic. Increasing evidence suggests that small molecular
eight oligomers correlate best with the disease and that insoluble amy-
oid plaques are not toxic [45] . It seems that the most toxic A 𝛽 is iden-
ified in A 𝛽42 . 
We also stress that a longitudinal analysis of the main hallmarks
f AD (though ignoring the role of 𝜏) is carried out in [5] . In particu-
ar, we see there that the total amount of soluble A 𝛽 in CSF decreases
hen the severity of the disease increases (see Fig. 5 in [5] ). This phe-
omenon is well known in clinical practice to establish an AD diagnosis
see e.g. [19] ). 
.3. Aims of the model 
Increasing clinical evidence suggests that A 𝛽 and 𝜏 do not act
n isolation and that there is significant crosstalk between these two
olecules [43] . Experiments using primary neurons or neuronal cell
ines have shown that application of A 𝛽 oligomers increases 𝜏 phospho-
ylation [48] . This suggests a link between A 𝛽 toxicity and 𝜏 pathology,
ut it is unclear how A 𝛽 and 𝜏 interact in pathological cases. Often 𝜏 is
laced downstream of A 𝛽 in a pathocascade, providing support for the
myloid cascade hypothesis [21] . In this context we present a multiscale
odel for the onset and evolution of AD which accounts for the diffu-
ion and agglomeration of A 𝛽 peptide, the protein 𝜏 and the spreading
f the disease. 
We stress that different spatial and temporal scales are needed to cap-
ure the complex dynamics of AD in a single model: microscopic spatial
cales to describe the role of the neurons, macroscopic spatial and short
emporal (minutes, hours) scales for the description of relevant diffusion
rocesses in the brain, and large temporal scales (years, decades) for the
escription of the global evolution of AD. 
Having these considerations in mind, the main purpose of the paper
s to provide a reliable and flexible mathematical tool for better investi-
ating mutual interaction mechanisms between A 𝛽 and 𝜏 and assess the
esulting effect on the dynamics of Alzheimer’s disease. Here reliability
efers to the underlying mathematics, while flexibility is a crucial re-
uirement which makes it possible to easily adapt the model to specific
odelling hypotheses that one decides to test. In the case of AD flex-
bility becomes particularly important since, due to its extreme com-
lexity, it is unthinkable to design a complete and global model from
cratch. Any serious attempt in this direction would require an unreal-
stic amount of parameters, with values which are often unknown and
ifficult to estimate. Therefore we restrict ourselves to the design of the
athematical structure of the model, focussing on a limited amount of
iomedical processes. In the present paper we focus on the role of possi-
le interactions between A 𝛽 and phosphorylated 𝜏. In particular we test
he hypothesis that their “cooperation ” in the neuronal damage through
ifferent mechanisms is relevant for the evolution of the disease. In a
implified problem, which for example completely neglects the complex
eometry of the brain, we show that in specific parameter regimes this
s indeed the case. 
. The mathematical model 
The mathematical model employed in the present study derives from
hat extensively described, analyzed and motivated in [5,7,8] . Modifi-


























































































































a  ations to the original model are made to cope with the main focus of
he present study: the interplay between A 𝛽 and 𝜏. 
We identify a portion of cerebral tissue by an either two- or three-
imensional bounded set Ω. The space variable is denoted by 𝑥 . Two
ime scales are needed to describe the evolution of the disease over a
eriod of years: a short (i.e., rapid) 𝑠 -scale, where the unit time coincides
ith hours, for the diffusion and agglomeration of A 𝛽 [37] ; and a long
i.e., slow) 𝑡 -scale, where the unit time coincides with several months,
or the progression of AD. Introducing a small constant 0 < 𝜀 ≪ 1 , the
elationship between these two time scales can be expressed as 
 = 𝜀𝑠. (1)









𝜕 𝑡 𝑓 + 𝜕 𝑎 ( 𝑓 𝑣 [ 𝑓 ]) = 𝐽 [ 𝑓 ] in Ω × [0 , 1] × (0 , 𝑇 ] (2a
𝜀𝜕 𝑡 𝑢 1 − 𝑑 1 Δ𝑢 1 = − 𝛼𝑢 1 𝑈 +  [ 𝑓 ] − 𝜎1 𝑢 1 in 𝑄 𝑇 = Ω × (0 , 𝑇 ] (2b




1 − 𝛼𝑢 2 𝑈 − 𝜎2 𝑢 2 in 𝑄 𝑇 (2c




3 ≤ 𝑗+ 𝑘< 6 𝑢 𝑗 𝑢 𝑘 in 𝑄 𝑇 (2d
𝜕 𝑡 𝑤 = 𝐶 𝑤 ( 𝑢 2 − 𝑈 𝑤 ) + + ∫Ω ℎ 𝑤 ( |𝑦 − 𝑥 |) 𝑤 ( 𝑦, 𝑡 ) 𝑑𝑦 in 𝑄 𝑇 , (2e






We recall that, given a real number 𝑧, the symbol 𝑧 + denotes the
ositive part of 𝑧, i.e. 𝑧 + = 𝑧 if 𝑧 ≥ 0 and 𝑧 + = 0 if 𝑧 < 0 . 
Equation (2e) is the equation for the density 𝑤 ( 𝑥, 𝑡 ) of intracel-
ular phosphorylated 𝜏 at a point 𝑥 ∈ Ω and time 𝑡 > 0 . The equa-
ions (2b), (2c), (2d) describe the dynamics of A 𝛽. Here 
(i) 𝑢 1 ( 𝑥, 𝑡 ) is the density of monomers in the point 𝑥 ∈ Ω at time 𝑡 > 0 ;
(ii) 𝑢 2 ( 𝑥, 𝑡 ) is the cumulative density of soluble oligomers, which are
regarded collectively as a single compartment; 
(iii) 𝑢 3 ( 𝑥, 𝑡 ) is the density of senile plaques. 
In particular, (2b) and (2c) are compartmental Smoluchowski-type
quations with diffusion, agglomeration and cleavage. A classical refer-
nce for Smoluchowski equations is [15,47] . Originally, these equations
ere introduced for the study of the aerosols; applications of Smolu-
howski system to the description of the agglomeration of A 𝛽 amyloid
ppeared for the first time in [40] and [1] . 
Such a compartmental model, which in particular does not distin-
uish the densities of the soluble oligomers based on their length, is
ustified by the fact that, according to the literature, there is no clinical
vidence on the maximum length of toxic A 𝛽 oligomers [23] . Therefore,
ny precise value of such a length would be partly arbitrary. Although
his may seem an over-simplification, in fact it is not because, as far as
he results of the model are concerned, considering a more detailed de-
cription of the soluble oligomers with their precise lengths, such as e.g.
n [5] , has proved not to add significant information [6,12] . The coeffi-
ient 𝜀 in front of the time derivatives is due to the relationship (1) , in
articular to the fact that, on the longer time scale 𝑡, the rate at which
gglomeration and diffusion of A 𝛽 take place is as high as 1 
𝜀 
. Observe
hat we could rescale 𝜀, for example, by the proportion of an hour and a
onth: 𝜀 = 0 . 0014 × ?̃? ; this shows that 1∕ 𝜀 is large but numerically quite
anageable. Equation (2d) for the fibrils is written in the same spirit, ex-
ept for the fact that fibrils are assumed not to move. Thus the equation
or their concentration 𝑢 3 does not feature a diffusion term. We include
n this compartment all the combinations of monomers and oligomers
roducing A 𝛽 entities other than those comprised in the compartments
 and 2, taking further into account that senile plaques do not aggregate
ith each other. Finally, consistently with the compartmental nature of
he model, we take the coagulation parameters constant and equal to
> 0 , neglecting the fact that they may feature a dependence on the
pecific lengths of the aggregating oligomers, see [5] . We have chosen 𝛼
s a positive parameter; one could also choose 𝛼 age-dependent, or take3 = 0 for young persons with healthy brains which do not produce toxic
ligomers. Since senile plaques were also found in “healthy brains ”, we
ave preferred to take 𝛼 > 0 and introduce in (3) the modelling hypothe-
is that there is a positive threshold 𝑈 for the density of oligomers below
hich toxic effects do not occur (see also the discussion following for-
ula (3) ). 
The isotropic diffusion Laplace operator Δ in the Smoluchowski
quations (2b) and (2c) is a severe modelling simplification that com-
letely ignores the complex structure of the cerebral parenchyma, and in
articular of the white matter. Soluble A 𝛽 diffuses in and is transported
y cerebral liquid (essentially water) but in this paper we have chosen
ot to model the dynamics of the cerebral fluid. Due to its flexibility
he model could, at least in principle, be extended in this sense, but the
opic is so complex that we prefer not to deal with it in the present pa-
er. The brain is full of barriers (cell membranes, axons, myelin, etc.)
hich makes the microscopic (say at the size of an MRI-voxel), diffu-
ion of the fluid highly anisotropic. For example, diffusion tends to be
arger along the long axis of an axonal tract, and it could be influenced
y myelin damage. An extensive discussion of the subject can be found
.g. in [2–4] , in connection with the technique of Diffusion Tensor Imag-
ng (DTI) and its diagnostic clinical applications. Mathematically, good
nowledge of the microscopic diffusion can be translated to macroscopic
quations through homogenization techniques (see for example [16–
8] , for homogenization procedures in the context of Smoluchowski
quations applied to the modelization of AD). The resulting macroscopic
nd anisotropic diffusion operator is of the type ∇ ⋅ ( 𝐷 ∗ ( 𝑥, 𝑡 )∇) , where
he diffusion matrix 𝐷 ∗ ( 𝑥, 𝑡 ) keeps memory of the microscopic diffu-
ion and the geometry of the brain. Obviously it is highly nontrivial
o translate all this in quantitative information about 𝐷 ∗ ( 𝑥, 𝑡 ) . A sec-
nd important problem is a possible convective contribution to the fluid
ow. For example, the introduction of the concept of glymphatic system
see, e.g. [25,50] ) naturally leads to the modelling assumption that a
onvective contribution of the fluid flow is crucial for clearance mech-
nisms. For example, toxic A 𝛽 oligomers could be eliminated from the
rain by the fluid flow. The precise mechanism of convective flow in
he parenchyma is still unknown, and its role in clearance mechanisms
s still discussed in the medical literature. We mention that an interest-
ng new mathematical technique which gives quantitative information
bout the fluid flow in the brain was recently introduced in [31] . 
Given the complexity of the fluid flow, in the present paper we have
hosen to assume that the diffusion of A 𝛽 simply isotropic, while the
erms − 𝜎1 𝑢 1 in (2b) and − 𝜎2 𝑢 2 in (2c) are meant to keep into account
everal clearance phenomena, mainly due to phagocytic activity of the
icroglia. We are fully aware of the oversimplification of these choices,
ut we have preferred to focus on the possible interaction between A 𝛽
nd 𝜏. 
Equation (2a) is a key ingredient of our approach of the model: a
inetic-type equation which describes the progression of the disease.
oughly speaking, 𝑓 = 𝑓 ( 𝑥, 𝑎, 𝑡 ) is the probability density of the degree
f malfunctioning 𝑎 ∈ [0 , 1] of neurons located in 𝑥 ∈ Ω at time 𝑡 > 0 and
s such that 𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎 represents the fraction of neurons in 𝑥 which
t time 𝑡 have a degree of malfunctioning comprised between 𝑎 and
 + 𝑑𝑎 . For a precise mathematical formulation in terms of probability
easures, see [8] . We assume that 𝑎 close to 0 stands for “the neuron is
ealthy ” whereas 𝑎 close to 1 stands for “the neuron is dead ”. 
The progression of AD occurs on the longer time scale 𝑡, over decades,
nd is determined by the deterioration rate 𝑣 [ 𝑓 ] = 𝑣 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) , which we
ssume to have the following form: 
 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) = 𝐶  ∫
1 
0 
( 𝑏 − 𝑎 ) + 𝑓 ( 𝑥, 𝑏, 𝑡 ) 𝑑𝑏 + 𝐶  (1 − 𝑎 ) ( 𝑢 2 ( 𝑥, 𝑡 ) − 𝑈 ) 
+ 
+ 𝐶  (1 − 𝑎 ) 𝑤 ( 𝑥, 𝑡 ) . (3) 
he integral term describes the propagation of AD among close neurons.
he second term models instead the action of toxic A 𝛽 oligomers, lead-
ng ultimately to apoptosis. The threshold 𝑈 > 0 indicates the minimal
mount of toxic A 𝛽 needed to damage neurons. Finally, 𝐶  , 𝐶  > 0 are

















































































































𝑈  roportionality constants. The third term accounts for the toxicity of the
hosphorylated 𝜏, whose density in the point 𝑥 ∈ Ω at time 𝑡 > 0 is de-
oted by 𝑤 ( 𝑥, 𝑡 ) . Specifically, this term assumes that such a toxicity is
roportional to the concentration 𝑤 through a proportionality constant
  > 0 and that it is modulated by the current degree of malfunctioning
f the neurons, in such a way that the more damaged the neurons the
ower the impact of the toxic 𝜏 on them. 
The term 𝐽 [ 𝑓 ] = 𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) on the right-hand side of (2a) describes
he possible random onset of AD in portions of the domain Ω as a result
f a microscopic stochastic jump process. The latter takes into account
he possibility that the degree of malfunctioning of neurons randomly
umps to higher values due to external agents or genetic factors. The
xplicit expression of this term is 





𝑃 ( 𝑡, 𝑥, 𝑎 ∗ → 𝑎 ) 𝑓 ( 𝑥, 𝑎 ∗ , 𝑡 ) 𝑑𝑎 ∗ − 𝑓 ( 𝑥, 𝑎, 𝑡 ) 
) 
, (4)
here 𝑃 ( 𝑡, 𝑥, 𝑎 ∗ → 𝑎 ) denotes the probability that the degree of malfunc-
ioning of neurons in the point 𝑥 ∈ Ω jumps at time 𝑡 > 0 from 𝑎 ∗ to
 > 𝑎 ∗ . The coefficient 𝜂 > 0 is the jump rate. 
It is worth stressing that (2a), together with the detailed expressions
3), (4) of the terms 𝑣 [ 𝑓 ] , 𝐽 [ 𝑓 ] , may be obtained from a mesoscopic
escription of a microscopic model of neuron-to-neuron interactions as
hown in [7] . In addition, we will show in Section 2.2.1 that 𝐽 [ 𝑓 ] is
losely related to both the onset of AD and to a measure of average neu-
onal dysfunction; the latter of which could be measured, for instance,
y positron emission tomography (PET) imaging techniques. In partic-
lar, we will show that an expression for the average local degree of
euronal dysfunction is bounded above by an expression determined by
  and that, in the small time limit, dysfunction behaves as 𝜂∕2 𝑡 ; thus,
howing that the random dysfunction rate 𝜂 > 0 is necessary for the ini-
iation of AD pathology in this model. 
As we have explained before, the main purpose of the paper is to
ntroduce a simplified scheme of interaction between A 𝛽 and 𝜏, as pro-
osed for instance in [27] . It is known that A 𝛽-plaques proximal to neu-
onal cell bodies can instigate, and exacerbate, 𝜏-pathology [27,42,44] .
owever, there is no current evidence that 𝜏 influences A 𝛽-pathology in
umans [44] ; moreover, a recent NIA-AA panel study suggests that all
linical diagnoses on the AD spectrum [28] should require the presence
f A 𝛽-pathology biomarkers but not necessarily 𝜏 biomarkers. Based on
he above we state an explicit modelling hypothesis used in our model:
hat some minimal level of A 𝛽-aggregation is required to initiate 𝜏-pathology .
his assumption is encoded by the term 𝐶 𝑤 ( 𝑢 2 − 𝑈 𝑤 ) + in (2e), where pa-
ameter 𝐶 𝑤 > 0 is a proportionality constant. It is a built-in feature of
ur model that in equation (2e) the evolution of 𝜏 phosphorilation is
nly due to the toxic effect of A 𝛽. This could suggest that the model is
omehow too reminiscent of a “purely amyloid hypothesis ”. From the
athematical point of view, the addition of a source term in (2e) would
ot alter significantly the structure of the equations and, consequently,
he outcomes of the simulations. Therefore we preferred this simplified
ormulation. 
In (3) , the formula of the deterioration rate 𝑣 [ 𝑓 ] , the term 𝐶  (1 −
 ) 
(
𝑢 2 ( 𝑥, 𝑡 ) − 𝑈 
)+ 
takes into account the toxic action of A 𝛽 and 𝐶  (1 −
 ) 𝑤 ( 𝑥, 𝑡 ) that of 𝜏. 
The second term on the right-hand side of (2e) describes the prion-
ike non-local spreading of the phosphorylated 𝜏 in possibly distant
oints of the brain according to the spatial kernel ℎ 𝑤 . In Section 2.2 we
ill investigate in detail some properties of this integral term, which
ill further elucidate its physical meaning. We assume that the dynam-
cs of 𝜏 take place on the slow time scale 𝑡 . In the absence of precise
ndications from the biomedical literature, this choice seems reasonable
n view of the fact that 𝜏 is especially involved in the progression of the
isease rather than in the A 𝛽 agglomeration and the consequent forma-
ion of senile plaques. 
To conclude the presentation of the model, we mention that the term
[ 𝑓 ] =  [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) in (2b) describes the production of A 𝛽 monomers
4 y neurons, taking into account that, up to a certain extent, damaged
eurons increase such a production. In view of these considerations, we
hoose 
[ 𝑓 ]( 𝑥, 𝑡 ) = 𝐶  ∫
1 
0 
( 𝜇0 + 𝑎 )(1 − 𝑎 ) 𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎. (5)
ere, the small constant 𝜇0 > 0 accounts for A 𝛽 production by healthy
eurons while the factor 1 − 𝑎 expresses the fact that dead neurons do
ot produce amyloid. As usual, 𝐶  > 0 is a proportionality constant.
gain the flexibility of the model makes it possible to take into account
he possible role of 𝜏 in the production of A 𝛽 monomers, as we have
ketched in Section 1.2 . 
.1. Initial and boundary conditions 
As far as boundary conditions are concerned, we assume that 𝜕Ω
onsists of two smooth disjoint parts, say 𝜕Ω0 and 𝜕Ω1 , being 𝜕Ω0 the
uter boundary which delimits the considered portion of cerebral tissue
nd 𝜕Ω1 the inner boundary of the cerebral ventricles. On 𝜕Ω0 we pre-
cribe classical no-flux conditions for all the concentrations. Conversely,
n 𝜕Ω1 we prescribe a Robin condition for the concentrations of the A 𝛽
ligomer mimicking their removal by the cerebrospinal fluid through






∇ 𝑢 𝑖 ⋅ 𝐧 = 0 on 𝜕Ω0 , 𝑖 = 1 , 2 
∇ 𝑢 𝑖 ⋅ 𝐧 = − 𝛽𝑢 𝑖 on 𝜕Ω1 , 𝑖 = 1 , 2 
∇ 𝑤 ⋅ 𝐧 = 0 on 𝜕Ω, 
(6) 
here 𝛽 > 0 is a proportionality parameter and 𝐧 the outward normal
nit vector to 𝜕Ω. The choice of the right-hand side of the above Robin
ondition, in absence of experimental data, is the simplest possible.
aybe a more realistic choice would be 
 𝑢 𝑖 ⋅ 𝐧 = − ℎ ( 𝑢 𝑖 ) on 𝜕Ω1 , 𝑖 = 1 , 2 , 
here ℎ ( 𝑢 𝑖 ) ≈ 𝛽𝑢 𝑖 as 𝑢 𝑖 → 0 , and ℎ ( 𝑢 𝑖 ) ≈ 1 as 𝑢 𝑖 → ∞. 
We also complement system (2) with a proper set of initial condi-
ions: 
( 𝑥, 𝑎, 0) = 𝑓 0 ( 𝑥, 𝑎 ) , 𝑢 𝑖 ( 𝑥, 0) = 𝑢 0 ,𝑖 ( 𝑥 ) ( 𝑖 = 1 , 2 , 3) , 𝑤 ( 𝑥, 0) = 0 . (7)
A numerical discretisation of the initial/boundary-valued prob-
em (2)- (6) - (7) can be set up straightforwardly by adapting the one de-
cribed in detail in [5] . 
.2. Mathematical insights from the model 
In order to familiarise with model (2) and to grasp the biological
eaning of several complex terms appearing in the equations, in this
ection we address some biologically relevant issues that can be tack-
ed with suitably simplified but illustrative instances of (2). These case-
ependent simplifications will make (2) more amenable to analytical
nvestigations and, at the same time, will provide a more intuitive feel-
ng about the whole model and the way in which it works. 
.2.1. AD onset 
The first issue that we investigate by means of (2) is how quickly
ompletely healthy neurons at a point 𝑥 ∈ Ω of the brain tissue start
eteriorating. To dig into this aspect, we mainly consider equation (2a)
ogether with the expression (3) of the deterioration rate of the neurons
nd we prescribe the initial conditions (7) with in particular 
 0 ( 𝑥, 𝑎 ) = 𝑔 ( 𝑥 ) 𝛿( 𝑎 ) , 𝑢 0 , 2 ( 𝑥 ) = 0 , (8)
being any spatial distribution of the neurons. These conditions depict
n initially healthy brain. 
Next, we assume that up to a certain time 𝑡 ∗ > 0 we have 𝑢 2 ( 𝑥, 𝑡 ) <
 , 𝑈 for all 𝑥 ∈ Ω, so that for 𝑡 ≤ 𝑡 ∗ it results ( 𝑢 ( 𝑥, 𝑡 ) − 𝑈 ) + = 0 in (2e)𝑤 2 𝑤 














































































nd analogously ( 𝑢 2 ( 𝑥, 𝑡 ) − 𝑈 ) + = 0 in (3) . Consequently, from (2e) we
btain 𝑤 ( 𝑥, 𝑡 ) = 0 and from (3) 
 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) = 𝐶  ∫
1 
0 
( 𝑏 − 𝑎 ) + 𝑓 ( 𝑥, 𝑏, 𝑡 ) 𝑑𝑏, 
o that (2a) takes the form 
 𝑡 𝑓 ( 𝑥, 𝑎, 𝑡 ) + 𝐶  𝜕 𝑎 
( 





( 𝑏 − 𝑎 ) + 𝑓 ( 𝑥, 𝑏, 𝑡 ) 𝑑𝑏 
) 
= 𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) , 
(9) 
here the term 𝐽 [ 𝑓 ] is given by (4) . We may now take advantage of
9) to investigate the local onset of AD in an initially healthy brain. 
First of all, we notice that 𝑣 [ 𝑓 ]( 𝑥, 1 , 𝑡 ) = 0 for all 𝑥 ∈ Ω and 𝑡 > 0 . If we
rescribe the further boundary condition 𝑓 ( 𝑥, 0 , 𝑡 ) = 0 for all 𝑥 ∈ Ω and
 > 0 , which is consistent with the fact that no degree of malfunctioning
 < 0 is admitted by the model, then by integrating (9) with respect to
 and noticing from (4) that ∫ 1 0 𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎 = 0 by construction, we
iscover 
 𝑡 𝜌( 𝑥, 𝑡 ) = 0 , 
here 
( 𝑥, 𝑡 ) ∶= ∫
1 
0 
𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎 
enotes the local percentage of neuronal mass at time 𝑡 . Therefore the
ass of neurons is conserved both locally and globally, consistently with
he modelling assumption that neurons are fixed in space and are neither
reated nor destroyed. It is worth pointing out that in our model the
ossible brain atrophy caused by AD is indeed not modelled explicitly
s a physical loss of neuronal mass. 
Second, multiplying (9) by 𝑎 and then integrating as before we obtain
n evolution equation for the local mean degree of neuronal malfunc-
ioning 
 ( 𝑥, 𝑡 ) ∶= 1 
𝜌( 𝑥 ) ∫
1 
0 
𝑎𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎, 
here 𝜌( 𝑥 ) stands for the constant-in-time local percentage of neuronal
ass at 𝑥 ∈ Ω. Specifically: 
𝜕 𝑡 𝐴 ( 𝑥, 𝑡 ) − 
𝐶  





( 𝑏 − 𝑎 ) + 𝑓 ( 𝑥, 𝑏, 𝑡 ) 𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑 𝑏 𝑑 𝑎 
= 1 
𝜌( 𝑥 ) ∫
1 
0 
𝑎𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎. (10) 
he quantity 𝐴 ( 𝑥, 𝑡 ) provides an observable macroscopic picture of AD
rends in the brain, in particular the initial onset for small 𝑡 and can
e compared with medical images from Fluorodeoxyglucose PET (FDG-
ET: see, e.g., [39] , [10] , [35] ). We anticipate that in the numerical
imulations of Section 3 we will explore instead its large time trend. 
To make the term ∫ 1 0 𝑎𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎 amenable to explicit computa-
ions, we take for the jump probability 𝑃 ( 𝑡, 𝑥, 𝑎 ∗ → 𝑎 ) , cf. (4) , the repre-
entative expression already introduced in [5,7,8] : 1 
 ( 𝑡, 𝑥, 𝑎 ∗ → 𝑎 ) = 
2 
1 − 𝑎 ∗ 
𝜒[ 𝑎 ∗ , 
1+ 𝑎 ∗ 
2 ] 
( 𝑎 ) , 
amely a uniform probability distribution of the post-jump degree of
alfunctioning 𝑎 in the interval [ 𝑎 ∗ , 
1+ 𝑎 ∗ 
2 ] . This complies with the re-
uirement of physical consistency 𝑎 ∗ ≤ 𝑎 ≤ 1 for all pre-jump degree of1 Here and henceforth, 𝜒𝐸 denotes the characteristic function of the set 𝐸, 
.e. 
𝐸 ( 𝑎 ) = 
{ 
1 if 𝑎 ∈ 𝐸 
0 otherwise . 
ℎ
5 alfunctioning 𝑎 ∗ ∈ [0 , 1] . Notice that, for the sake of simplicity, such
 𝑃 is homogeneous in time and space. With this choice, we get 
1 
𝜌( 𝑥 ) ∫
1 
0 
𝑎𝐽 [ 𝑓 ]( 𝑥, 𝑎, 𝑡 ) 𝑑𝑎 = 𝜂
2 
(1 − 𝐴 ( 𝑥, 𝑡 )) . (11)
For 𝑎, 𝑏 ∈ [0 , 1] it can be checked that 0 ≤ ( 𝑏 − 𝑎 ) + ≤ 𝑏 (1 − 𝑎 ) , whence
 simple computation yields 
 ≤ 𝐶  





( 𝑏 − 𝑎 ) + 𝑓 ( 𝑥, 𝑏, 𝑡 ) 𝑓 ( 𝑥, 𝑎, 𝑡 ) 𝑑𝑏 𝑑𝑎 
≤ 𝐶  𝜌( 𝑥 ) 𝐴 ( 𝑥, 𝑡 )(1 − 𝐴 ( 𝑥, 𝑡 )) . (12) 
Plugging (11), (12) into (10) we obtain the estimates 
𝜂
2 
(1 − 𝐴 ( 𝑥, 𝑡 )) ≤ 𝜕 𝑡 𝐴 ( 𝑥, 𝑡 ) ≤ 𝐶  𝜌( 𝑥 ) 𝐴 ( 𝑥, 𝑡 )(1 − 𝐴 ( 𝑥, 𝑡 )) + 𝜂2 (1 − 𝐴 ( 𝑥, 𝑡 )) , 
hich, by an integration in time from the initial condition 𝐴 ( 𝑥, 0) = 0
erived from (8) , produce 
 − 𝑒 − 
𝜂
2 𝑡 ≤ 𝐴 ( 𝑥, 𝑡 ) ≤ 1 − 𝐶  𝜌( 𝑥 ) + 
𝜂
2 
𝐶  𝜌( 𝑥 ) + 𝜂2 𝑒 
( 𝐶  𝜌( 𝑥 )+ 𝜂2 ) 𝑡 
. (13)
For 𝑡 → 0 + both bounds are asymptotic to 𝜂2 𝑡, therefore for 𝑡 small we
nfer 
 ( 𝑥, 𝑡 ) ∼ 𝜂
2 
𝑡. 
his indicates that the rate of AD onset is dictated by the frequency 𝜂 at
hich random neuron damages appear in the brain. Notice that if 𝜂 = 0
e obtain the exact solution 𝐴 ≡ 0 , which confirms that random jumps
re essential in the model to trigger the AD onset in a completely healthy
rain. On the other hand, (13) reveals that for larger times, however
uch that the A 𝛽-related terms in (2c), (2e) are still deactivated, the
ubsequent rate of AD progression depends also on the parameter 𝐶  ,
hich tunes the strength of AD propagation among close neurons, and
n the local percentage of neuronal mass 𝜌( 𝑥 ) . 
.2.2. Effect of the non-local term in (2e) 
Here we explore instead the effect of the non-local term 
( 𝑥, 𝑡 ) ∶= ∫Ω ℎ 𝑤 ( |𝑦 − 𝑥 |) 𝑤 ( 𝑦, 𝑡 ) 𝑑𝑦 (14)
n (2e) with Ω ⊂ ℝ 𝑛 ( 𝑛 = 2 , 3 from the physical point of view). With-
ut loss of generality, we assume that the function ℎ 𝑤 ∶ ℝ + → ℝ + is
uch that ℎ ′
𝑤 
(0 + ) = 0 . Furthermore, we assume that ℎ 𝑤 is compactly
upported in [0 , 𝑅 ] ⊂ ℝ , where 𝑅 > 0 denotes the maximum distance at
hich the prion-like influence of the phosphorylated 𝜏 is supposed to
e effective. Hence 
( 𝑥, 𝑡 ) = ∫𝐵 𝑅 ( 𝑥 ) ℎ 𝑤 ( |𝑦 − 𝑥 |) 𝑤 ( 𝑦, 𝑡 ) 𝑑𝑦. 
Assume that 𝑅 is sufficiently small, so that 𝑦 is close to 𝑥, and that
he functions ℎ 𝑤 , 𝑤 are smooth enough about 0 + and 𝑥, respectively. By
aylor expansion we find: 
 𝑤 ( |𝑦 − 𝑥 |) = ℎ 𝑤 (0 + ) + 1 2 ℎ ′′𝑤 (0 + ) |𝑦 − 𝑥 |2 + 𝑜 ( |𝑦 − 𝑥 |2 ) 
𝑤 ( 𝑦, 𝑡 ) = 𝑤 ( 𝑥, 𝑡 ) + 
𝑛 ∑
ℎ =1 






𝑥 ℎ 𝑥 𝑘 
𝑤 ( 𝑥, 𝑡 )( 𝑦 ℎ − 𝑥 ℎ )( 𝑦 𝑘 − 𝑥 𝑘 ) + 𝑜 ( |𝑦 − 𝑥 |2 ) , 
hus 
 𝑤 ( |𝑦 − 𝑥 |) 𝑤 ( 𝑦, 𝑡 ) = ℎ 𝑤 (0 + ) 𝑤 ( 𝑥, 𝑡 ) + ℎ 𝑤 (0 + ) 𝑛 ∑
ℎ =1 
𝜕 𝑥 ℎ 𝑤 ( 𝑥, 𝑡 )( 𝑦 ℎ − 𝑥 ℎ ) 
+ 1 
2 




𝑥 ℎ 𝑥 𝑘 
𝑤 ( 𝑥, 𝑡 )( 𝑦 ℎ − 𝑥 ℎ )( 𝑦 𝑘 − 𝑥 𝑘 ) 
+ 1 ℎ ′′
𝑤 
(0 + ) 𝑤 ( 𝑥, 𝑡 ) |𝑦 − 𝑥 |2 + 𝑜 ( |𝑦 − 𝑥 |2 ) . 2 























































































eglecting the remainder 𝑜 ( |𝑦 − 𝑥 |2 ) , we can therefore approximate
( 𝑥, 𝑡 ) locally as 




𝜕 𝑥 ℎ 𝑤 ( 𝑥, 𝑡 ) ∫𝐵 𝑅 ( 𝑥 ) ( 𝑦 ℎ − 𝑥 ℎ ) 𝑑𝑦 
+ 1 
2 




𝑥 ℎ 𝑥 𝑘 





(0 + ) 𝑤 ( 𝑥, 𝑡 ) ∫𝐵 𝑅 ( 𝑥 ) |𝑦 − 𝑥 |2 𝑑𝑦. 
Let 𝜔 𝑛 denote the volume of the unit ball in ℝ 𝑛 . By switching to polar
oordinates, we find 
∫𝐵 𝑅 ( 𝑥 ) 𝑑𝑦 = 𝜔 𝑛 𝑅 
𝑛 , 
∫𝐵 𝑅 ( 𝑥 ) ( 𝑦 ℎ − 𝑥 ℎ ) 𝑑𝑦 = 0 , 
∫𝐵 𝑅 ( 𝑥 ) ( 𝑦 ℎ − 𝑥 ℎ )( 𝑦 𝑘 − 𝑥 𝑘 ) 𝑑𝑦 = 
⎧ ⎪ ⎨ ⎪ ⎩ 
𝜔 𝑛 
𝑛 +2 𝑅 
𝑛 +2 if ℎ = 𝑘 
0 if ℎ ≠ 𝑘, 
∫𝐵 𝑅 ( 𝑥 ) |𝑦 − 𝑥 |2 𝑑𝑦 = 𝑛𝜔 𝑛 𝑛 + 2 𝑅 𝑛 +2 , 
hence finally 
( 𝑥, 𝑡 ) ≈ 𝜔 𝑛 𝑅 𝑛 
( 
ℎ 𝑤 (0 + )+ 
𝑛 
2( 𝑛 + 2) 
ℎ ′′
𝑤 
(0 + ) 
) 
𝑤 ( 𝑥, 𝑡 )+ 
𝜔 𝑛 𝑅 
𝑛 +2 
2( 𝑛 + 2) 
ℎ 𝑤 (0 + )Δ𝑤 ( 𝑥, 𝑡 ) .
This shows that the local contribution of 𝐼( 𝑥, 𝑡 ) to the spreading of the
hosphorylated 𝜏 consists in a source term proportional to the quantity
f 𝜏 already present in the site 𝑥 and in a linear diffusion. 
The local approximation of 𝐼( 𝑥, 𝑡 ) elucidates also the role of the
ointwise values of ℎ 𝑤 , ℎ 
′′
𝑤 
in 𝑟 = 0 . If, for instance, we take 2 
 𝑤 ( 𝑟 ) = 
1 
𝜔 𝑛 𝑅 
𝑛 
𝜒[0 ,𝑅 ] ( 𝑟 ) , 
hich makes 𝐼( 𝑥, 𝑡 ) a uniform average of 𝑤 in a neighbourhood of 𝑥 of
adius 𝑅, then ℎ 𝑤 (0 + ) = 
1 
𝜔 𝑛 𝑅 
𝑛 and ℎ 
′′
𝑤 
(0 + ) = 0 , whence 
( 𝑥, 𝑡 ) ≈ 𝑤 ( 𝑥, 𝑡 ) + 𝑅 
2 
2( 𝑛 + 2) 
Δ𝑤 ( 𝑥, 𝑡 ) . (15)
his implies that, at the leading order in 𝑅, 𝐼 consists in a pointwise
ource and, at higher order, an isotropic diffusion term responsible for
he spatial spreading of the phosphorylated 𝜏. Notice that such a point-
ise approximation of 𝐼( 𝑥, 𝑡 ) is consistent with the isotropic approxi-
ation of the diffusion tensor in (2b), (2c) discussed on page 5. 
.2.3. A 𝛃-distribution in a healthy brain 
Determining the distribution of A 𝛽 in a healthy brain is relevant be-
ause it provides a consistent initial condition for studying AD initiation
rocesses. Moreover, it may also suggest how the geometry of the do-
ain Ω, thus the brain conformation, affects the result. 
We already discussed a proper set of initial conditions for model (2)
imulating a healthy brain, cf. (7), (8) . The point here is to characterise
he resulting distribution 𝑢 1 of non-toxic A 𝛽 monomers, which is essen-
ially ruled by (2b). 
Assume that the individual is young, say under 40 years of age,
nd healthy, in particular with no genetic predisposition to AD. Then
t makes sense to consider 𝛼 = 0 in (2) and 𝜂 = 0 in (4) , which imply no
oagulation of non-toxic A 𝛽 monomers into toxic polymers and no ran-
om damages of the neurons, respectively. From Section 2.2.1 we know
hat the latter condition produces 𝐴 ≡ 0 , which in turn implies that the
istribution 𝑓 of the degree of malfunctioning has remained propor-
ional to a Dirac delta centred in 𝑎 = 0 like in the initial condition (8) .2 For the meaning of 𝜒[0 , 𝑅 ] ( 𝑟 ) , cf. footnote 1 on page 8. 
6 his is so because 𝐴 is, by definition, the (local) mean of 𝑎 ∈ [0 , 1] , cf.
10) , and if the mean is zero then the probability distribution of 𝑎 has
o be concentrated at 0. Hence 𝑓 ( 𝑥, 𝑎, 𝑡 ) = 𝑔 ( 𝑥 ) 𝛿( 𝑎 ) . 
On the whole, from (5) we obtain 
[ 𝑓 ]( 𝑥, 𝑡 ) = 𝐶  𝜇0 𝑔( 𝑥 ) , 
hich plugged into (2b) yields 
𝜕 𝑡 𝑢 1 − 𝑑 1 Δ𝑢 1 = 𝐶  𝜇0 𝑔( 𝑥 ) − 𝜎1 𝑢 1 . 
ince 𝜀 is small, on the time scale 𝑡 of the AD progression we may well as-
ume that the distribution of A 𝛽 monomers is quasi-static. Consequently,
ecalling also the boundary conditions (6) , the physiological distribution
 1 = 𝑢 1 ( 𝑥 ) of A 𝛽 monomers in a healthy brain is fully characterised by






− 𝑑 1 Δ𝑢 1 + 𝜎1 𝑢 1 = 𝐶  𝜇0 𝑔( 𝑥 ) in Ω
∇ 𝑢 1 ⋅ 𝐧 = 0 on 𝜕Ω0 
∇ 𝑢 1 ⋅ 𝐧 = − 𝛽𝑢 1 on 𝜕Ω1 . 
(16) 
As already recalled in Section 2.2.1 , the function 𝑔 describes the con-
entration (statistical distribution) of the neurons in the cerebral tissue.
he simplest choice is to consider a homogeneous distribution, which
mounts to letting 3 
( 𝑥 ) = 1 |Ω|𝜒Ω( 𝑥 ) , 
here |Ω| denotes the Lebesgue measure (the area or the volume in
he physically relevant two- or three-dimensional cases) of Ω. Non-
omogeneous distributions are obviously also possible, if one wants to
ake into account the heterogeneity of the neuron concentration in the
rain. Problem (16) clearly shows that such a heterogeneity in general
as an impact on the physiological distribution of A 𝛽 monomers. 
. Numerical results 
The main purpose of this section is to numerically validate the model
reviously introduced. More specifically, our model can be schematized
s follows: 
• the A 𝛽 diffuses in the cerebral parenchyma undergoing a coagulation
process leading ultimately to the formation of senile plaques. In its
oligomeric form, the A 𝛽 induces the phosphorylation of the intra-
neural 𝜏 protein. 
• A 𝛽 and 𝜏 have a synergistic toxic effect on the neurons. 
The model we present here, for what purely concerns the A 𝛽, is akin
o the model presented in [5] within a strict Amyloid Cascade Hypoth-
sis, using a compartmental model with only two aggregating species
onomers and dimers. Oligomers with length longer than two are con-
idered as plaques, thus assuming 𝑁 = 3 . In addition, the initial data at
 = 0 are taken to represent a healthy brain, i.e. we take 
( 𝑥, 𝑎, 0) = 𝛿( 𝑎 ) , 𝑢 𝑖 ( 𝑥, 0) = 𝑢 0 ,𝑖 ( 𝑥 ) ( 𝑖 = 1 , 2 , 3) , 𝑤 ( 𝑥, 0) = 0 . 
In Section 2 we extensively discussed various other modelling simpli-
cations (such as that of isotropic diffusion). As we have announced in
he Introduction, in the present section we add two more essential sim-
lifications: we present two-dimensional numerical simulations and we
eglect the fine geometric complexity of the brain. In fact, in all figures
he numerical domain is a rectangle and represents a two dimensional
ection of the brain where the upper part is the frontal region, the lower
art is the occipital region and the two inner rectangles are the ven-
ricles. In addition, as in [5] , we consider privileged directions for the
ropagation of the disease (such as those corresponding to denser neural
undles) mimicked by two triangles, with bases in the occipital region
nd vertices in the hyppocampus. 3 For the meaning of 𝜒Ω( 𝑥 ) , cf. footnote 1 on page 8. 
M. Bertsch, B. Franchi, V. Meschini et al. Brain Multiphysics 2 (2021) 100020 
Table 1 
Values of the fixed parameters. 
𝐶 𝐺 𝐶 𝑆 𝐷 𝜎 𝜇0 𝐶 𝐹 𝐶 𝑊 𝑈 𝑤 
10 −1 10 −3 10 −2 1 10 −2 10 10 10 −2 
Table 2 
All the simulated cases and involved parameters 
with respective values. 
Inclusion of 𝜏 𝛼 𝛽 𝑈 
Case 1 No 10 1 10 −2 
Case 1.1 No 10 1 10 −1 
Case 2 Yes 10 1 10 −2 
Case 2.1 Yes 1 1 10 −2 





































































































4 The concept of quasi-steady state refers to a very slow evolution which, in 
the mathematical literature, is often referred to as quasi-static. Finally, the non-local term 𝐼( 𝑥, 𝑡 ) , see (14) , is replaced in (2e) by its
eading term 𝑤 ( 𝑥, 𝑡 ) , cf. (15) . 
The model contains many parameters which are often not known.
e fix some of them (see Table 1 ) and vary other ones (see Table 2 ),
nd we have done this in such a way that the numerical experiments
ive some first insights concerning possible synergistic effects of 𝜏 and
 𝛽. More precisely, we focus on the following topics: 
• neurodegeneration in absence of 𝜏 (see Section 3.1 ); 
• the effects of including 𝜏 in the model and its synergistic interaction
with A 𝛽 (see Section 3.2 ); 
• the impact of the agglomeration rate 𝛼 on the disease progression
(see Section 3.3 ); 
• the effects of the removal rate 𝛽 in presence of 𝜏 (see Section 3.4 ); 
• the effects of the threshold value 𝑈 (see Section 3.1 ). 
These target topics are discussed in separate paragraphs in this sec-
ion presenting and discussing the numerical results of each dedicated
imulation of the mathematical model for Alzheimer’s disease described
n Section 2 . We show the evolution of AD in two different modeling
chemes: the first does not take into account the role of 𝜏, whereas the
econd includes 𝜏. We show spatial plots of the evolution of the degree
f neuronal dysfunction, expressed by the quantity 𝑓 in (2a), as well
s spatial plots of the concentration of the toxic polymers, plaques and
phosphorylated) 𝜏. 
As a consequence of the compartmental description of the A 𝛽
ligomers, we find that the numerical results are quite sensitive to the
onstant 𝑈 in (3) , which we will therefore tune accurately so as to ob-
erve in practice an evolution of the disease. In particular, a too high
alue of 𝑈 may easily hinder the effective toxicity of the cumulative
ensity 𝑢 2 of A 𝛽, thereby preventing the occurrence of the dynamics of
D. As a matter of fact, since the phosphorylated 𝜏 contributes to the
verall toxicity [41] , the spread of the disease may also occur for a rel-
tively high value of 𝑈 . 
Besides 𝑈 , the equation for 𝜏 (see (2e)) contains another threshold
onstant 𝑈 𝑤 to which our model results very sensitive. There exists a
mall critical range around 𝑈 𝑤 = 0 . 01 : for smaller values of 𝑈 𝑤 the role
f A 𝛽 is reduced to the mere phosphorylation of tau and significant de-
erioration is due to tau only; conversely, for higher values of 𝑈 𝑤 not
nough tau is phosphorylated to play a significant role in the deteriora-
ion process. Therefore we fix 𝑈 𝑤 = 0 . 01 in all numerical tests, a value
or which there is a synergistic effect of tau and A 𝛽 in the deterioration
rocess. 
This choice is consistent with the model we are developing, which
s supported by patient biomarkers [48] and experiments on transgenic
ice [27] . 
In both simulation set-ups (with and without 𝜏) we carry out a sort
f sensitivity analysis of the model outcomes with respect to the param-
ters 𝛼, 𝛽 and 𝑈 , also in view of possible clinical implications. 7 First of all, we consider the parameter 𝛽, which enters the model
hrough condition (6) at the boundary of the cerebral ventricles. Small
alues of 𝛽 mean that a small amount of A 𝛽 is removed from the CSF
hrough the choroid plexus. To test the sensitivity of the outcomes, we
ake for 𝛽 two values: 𝛽 = 0 . 01 and 𝛽 = 1 . Another significant parameter
s 𝛼 (the coagulation parameter in (2b), (2c)). We choose two different
rders of magnitude of 𝛼 to observe how it affects the dynamics of A 𝛽
n the brain. We run a simulations campaign (both with and without
ncluding 𝜏) varying 𝛼, 𝛽 and 𝑈 but keeping all other parameters fixed
see the captions in the sequel), with the values in Table 1 . These values
epresent orders of magnitude and have a proper unit measure that can
e deduced from the equations in which they are involved. 
We perform numerical tests of the various choices of the parameters
resented in Table 2 . The insights obtained from these simulations, es-
ecially those related to possible clinical treatments and procedures will
e discussed in Section 4 . 
.1. Neurodegeneration in absence of 𝛕
In this subsection we simulate the model for Alzheimer’s disease
hich was already presented in [5] , without the presence of 𝜏 but with
 = 3 . The only toxic oligomers are dimers and therefore the overall
oxicity level is much lower than in [5] , in which 𝑁 = 50 . The toxicity
evel enters the formula for the degree of malfunctioning of the brain,
hich provides information on the health state of the brain. The pa-
ameter 𝛼, which regulates the coagulation of monomers and dimers, is
aken equal to 10, while 𝛽, which refers to the portion of toxic oligomers
xtracted from the brain, is equal to 1. Given these parameter values,
e choose the threshold value 𝑈 for toxic 𝑢 2 equal to 10 −2 , which turns
ut to be the minimal order of magnitude to allow the disease to take
lace. In fact, if we set 𝑈 = 0 . 1 the degree of malfunctioning of the brain
oes not evolve in time and the disease does not spread (see Fig. 1 ). 
The numerical outputs with 𝑈 = 10 −2 are shown in Fig. 2 , where
he spatial plots of the degree of neuronal malfunctioning 𝑓 at different
imes are indicated. The disease originates from some random sources
the blue spots) and does not evolve. Due to the propagation of synaptic
ysfunction, it spreads to other portions of the brain until it reaches a
umerical equilibrium configuration, in the sense that the spatial plot of
does not change anymore if time evolves. In this “quasi-steady state ”4 
e can see that there is a blue zone (dead part) but the brain is not
ompletely ill. This result is clearly different from that obtained in [5] ,
n which the whole brain is blue thus meaning basically that the patient
s dead. 
The interpretation of this new phenomenon is the following, Since
he only toxic oligomers are dimers and having a coagulation factor
= 10 , the A 𝛽 monomers which aggregate to form dimers remain only
riefly in this toxic state and quickly become plaques which are non
oxic. Therefore the toxicity of the whole system is much lower. The
ormation of the quasi steady state has a similar explanation: at a certain
oint the concentration of toxic oligomers 𝑢 2 goes below the threshold
evel 𝑈 , because toxic dimers quickly agglomerate into plaques, and
he degree of malfunctioning does not evolve any further. In [5] the
henomenon was not observed since there 𝑁 = 50 instead of 𝑁 = 3 . 
.2. The interaction between A 𝛃 and 𝛕 and the role of 𝛕
Compared to [5] , the major novelty of the present paper is the in-
lusion of the toxic effects of 𝜏 in the model. In the mathematical model
e have added an equation describing the diffusion of 𝜏 and we have
ncluded its toxic effects on the degree of malfunctioning of the brain,
s described in Section 2.1 . In this subsection we keep the same param-
ter values as in Case 1 (see Table 2 ): 𝛼 = 10 , 𝛽 = 1 and 𝑈 = 0 . 01 . In
ig. 3 we present spatial plots of the degree of malfunctioning of the
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Fig. 1. (Case 1.1) spatial plots of the degree of 
malfunctioning of the brain for 𝛼 = 10 , 𝛽 = 1 , 
𝑈 = 0 . 1 and without 𝜏 at two time instants: a) 
𝑇 = 100 , b) 𝑇 = 10000 . 
Fig. 2. (Case 1) spatial plots of the degree of 
malfunctioning of the brain for 𝛼 = 10 , 𝛽 = 1 , 
𝑈 = 10 −2 and without 𝜏 at two time instants: a) 
𝑇 = 100 , b) 𝑇 = 600 . 
Fig. 3. (Case 2) spatial plots of the degree of 
malfunctioning of the brain for 𝛼 = 10 , 𝛽 = 1 
and 𝑈 = 0 . 01 with 𝜏 at two times: a) 𝑇 = 100 , 
b) 𝑇 = 600 . 
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Fig. 4. (Case 2) spatial plots of 𝜏 for 𝛼 = 10 , 
𝛽 = 1 and 𝑈 = 0 . 01 at two time instants: a) 𝑇 = 
100 , b) 𝑇 = 600 . 
Fig. 5. Case 2 with 𝐶 𝐺 = 0 : spatial plots of the 
degree of malfunctioning of the brain for 𝛼 = 
10 , 𝛽 = 1 , 𝑈 = 0 . 01 at two times: a) 𝑇 = 100 , b) 












































F  rain. Numerical simulations show that again a numerical steady state
a quasi-steady state) is reached, which is indicated in Fig. 3 (b). 
In this case (Case 2) the dynamics is different from that without 𝜏
Case 1): it is faster than that in Figs. 2 and follows the spreading trend
f the 𝜏 concentration (compare Figs. 3 and 4 ). Also the spatial local-
zation of completely ill regions (the blue regions) is larger than in the
ase without 𝜏 (compare Figs. 3 and 2 ). These results indicate that the
resence of 𝜏 influences the evolution of AD. Notice that Fig. 3 a is co-
erent with medical imaging (see, e.g. [38] and [5] , Fig. 6 ). As we al-
eady stressed above, previous simulations show that the presence of 𝜏
ccelerates the evolution of the disease. This seems coherent with the
ypothesis that different patterns for the evolution of AD (slow/fast),
nown in clinical literature are possibly generated by genetic variation
n patients, associated with different levels of phosphorylated 𝜏 in the
SF [13,49] . 
Numerically one gets better insight in the role of 𝜏 by ignoring the
euron-to-neuron infection mechanism. In other words we set the con-
tant 𝐶  of Section 2 equal to zero. Keeping the parameter values as in
ases 1 and 2, the spatial plot of the degree of malfunctioning in Fig. 5 is
ifferent from that in Figure 3 : the disease is less diffused in the cerebral
arenchyma, and brain damages are localized in a portion of the brain
here 𝜏 is concentrated. Moreover, the brain is divided into two sep-
rated regions: the occipital part that is totally damaged (blue region)
nd the rest that is completely healthy (red region). t  
9 In conclusion, neglecting the proximity infection mechanism be-
ween neurons reduces brain damages, and this confirms the toxic ef-
ects of the synergistic interactions between A 𝛽 and 𝜏 are higher than
heir single toxic effects. 
.3. The role of the agglomeration rate 𝛂
In this subsection we study the role of the agglomeration rate repre-
ented by the value of the parameter 𝛼. We carry out a simulation with
he parameters values of Case 2, used to obtain Fig. 3 , except the value
f 𝛼, which is reduced to from 10 to 1. This means that the aggregation
f monomers is slower with respect to Fig. 3 . The numerical output is
hown in Fig. 6 , where the spatial plots of the degree of malfunctioning
f the brain are plotted at two different instants. Unlike all cases seen so
ar, the disease spreads faster into the whole cerebral parenchyma, un-
il all the brain is already damaged at the computational time 𝑇 = 150 .
 first explanation of the phenomenon is that the transition of soluble
myloid into non-toxic plaques is much slower than in the case 𝛼 = 10 ,
nd therefore A 𝛽 remains longer in the toxic oligomeric state. Moreover,
ooking at the spatial distribution of 𝜏, see Fig. 7 , it is clear that, unlike
he previous simulations, 𝜏 spreads quickly on the whole brain, acceler-
ting the spread of the disease and the complete damaging of the brain.
rom the clinical point of view, this seems to suggest that accelerating
he coagulation could eventually slow down the progression of AD. This
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Fig. 6. (Case 2.1) spatial plots of the degree of 
malfunctioning for 𝛼 = 1 , 𝛽 = 1 , 𝑈 = 0 . 01 and 
inclusion of 𝜏 at two times: a) 𝑇 = 10 , b) 𝑇 = 
150 . 
Fig. 7. (Case 2.1) spatial plots of 𝜏 for 𝛼 = 1 , 
𝛽 = 1 and 𝑈 = 0 . 01 at two time instants: a) 𝑇 = 














































emark hints a connection between the choice of 𝛼 and clinical imaging
nd is therefore a good motivation for further work. 
.4. The effect of 𝛃 in presence of 𝛕
This paragraph aims to investigate the effects of the parameter 𝛽,
hich enters the equations of the model to represent the portion of toxic
 𝛽 that is removed from the brain by clearance mechanisms through the
horoid plexus. In this simulation we use the same set of parameters val-
es as in Fig. 3 , in particular keeping 𝛼 = 10 , except for the value of 𝛽
hat we set equal to 0.01 instead of 1. This means that a smaller amount
f toxic oligomers are removed from the brain with respect to Fig. 3 .
n Fig. 8 some snapshots of the spatial plots of the degree of malfunc-
ioning at two different instants are shown. The overall dynamics of the
preading of the disease is similar to that described in Fig. 3 , but the
umerical steady state is reached faster and the completely damaged
egion of the brain is larger. This result appears reasonable since if less
oxic elements are removed, then the degree of malfunctioning becomes
igher. In agreement with what was observed in Fig. 3 , the spatial plots
f the degree of malfunctioning reflects that of 𝜏 (see Fig. 9 ). Indeed,
in the present simulation is spread in a wider region. This is not sur-
rising because of the structure of the set of equation of our model. It
ight suggest to use some kind of “dialysis ” of the CSF, but, on the other
and, this perspective seems currently unrealistic since in clinical prac-10 ice it is well known that low pressure of the CSF causes headaches to
he patient. 
. Discussion 
The brains of patients affected by Alzheimer’s disease suffer from
trophy, and neuronal and synapse loss. Histopathologically they are
haracterized by two hallmark lesions: senile plaques containing A 𝛽 pep-
ides, and neuro fibrillary tangles (NFT), which are composed of hyper-
hosphorylated forms of 𝜏-protein. 
According to the Amyloid Cascade Hypothesis (ACH), A 𝛽 production
nd aggregation is a critical step in driving Alzheimer’s disease patho-
enesis. Indeed, there is substantial evidence that oligomeric A 𝛽 has a
ole in synapse degeneration. On the other hand, according to the ACH,
 𝛽 also triggers the hyperphosphorylation of the microtubule associated
rotein 𝜏 inducing circuit dysfunction.Therefore, a crucial question is
ow 𝜏 has to be placed in the ACH. 
Although A 𝛽 and 𝜏 show separate toxic mechanisms, their interac-
ion is not well understood. In [27] the authors envisage three possible
odes of interaction: a) A 𝛽 drives 𝜏 pathology by causing hyperphos-
horylation of 𝜏, which in turn mediates toxicity in neurons; b) 𝜏 me-
iates A 𝛽 toxicity and hence, A 𝛽 toxicity is critically dependent on the
resence of 𝜏 for example, in the dendrite; c) A 𝛽 and 𝜏 target cellular
rocesses or organelles synergistically, thereby possibly amplifying each
thers toxic effects. 
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Fig. 8. (Case 2.2) Spatial plots of the degree 
of malfunctioning for 𝛼 = 10 , 𝛽 = 0 . 01 , 𝑈 = 0 . 01 
and inclusion of 𝜏 at two times: a) 𝑇 = 10 , b) 
𝑇 = 100 . 
Fig. 9. Case 2.2) Spatial plots of 𝜏 for 𝛼 = 10 , 
𝛽 = 0 . 01 , 𝑈 = 0 . 01 at two time instants: a) 𝑇 = 


















































s  In the present paper we developed a set of equations describing the
nteraction between A 𝛽 and 𝜏, assuming hypothesis a) above, however
etting the model sufficiently adaptable to cover also different biological
ssumptions. 
Our set of equations consists of a system of Smoluchowki type equa-
ions with diffusion (describing the A 𝛽 coagulation and diffusion), a
ransport equation describing the evolution of the disease, and an evo-
ution equation for the hyperphosphorylation of 𝜏. We stress that our
quations contains several numerical parameters that we have to tune
arefully since most of them fail to have a precise value suggested by
linical data. Parameter tuning naturally leads to a sensitivity analysis
f the effects of some of the relevant parameters in the model on the
lobal dynamics of the disease. 
The first insight we extrapolate from our analysis concerns the coag-
lation parameter 𝛼 standing for the velocity at which monomers and
ligomers aggregate. We find out that setting 𝛼 at least equal to 10 (see
ig. 3 ) leads to a quasi steady state of the system in which only a portion
f the brain is damaged. The location and size of the damaged portion
lso depend on the values of the remaining parameters of the model.
his result has hypothetical clinical implications: it suggests the pos-
ibility of a drug therapy aiming to increase the aggregation rate of
onomers and oligomers in order to control and localize the deterio-
ation of the white matter. 
Concerning the effect of the parameter 𝛽, the toxic A 𝛽 removal rate,
umerical simulations validate the model, showing that higher values of11 correspond to more toxic A 𝛽 removed from the cerebral parenchyma
hus yielding a wider healthy region of the brain (see Fig. 3 ) with re-
pect to the results obtained with lower values of 𝛽 (see Fig. 8 ). This is in
greement with the clinical evidence that an efficient clearance mech-
nism can control the brain damages produced by the combined effect
f toxic A 𝛽 and 𝜏. Finally, comparing the cases with and without 𝜏 and
eeping all other parameters fixed, we clearly observe that the evolu-
ion of the disease is much faster and the damaged brain region larger
hen we include 𝜏 in the model. Looking at the spatial plots of the de-
ree of malfunctioning, Fig. 3 with inclusion of 𝜏 and Fig. 2 without,
his fact is evident. In conclusion, 𝜏 interacts with A 𝛽 accelerating the
athological dynamics of AD. This is coherent with the hypothesis that
ome authors formulate to explain different patters (slow/fast) of the
volution of AD in different patients: due to unknown genetic reasons,
n some individuals the CSF presents a higher rate of 𝜏 phosphorylation,
hus accelerating the progress of the disease. 
In addition, numerical simulations suggest a further facet of the in-
eraction of A 𝛽 and 𝜏: if A 𝛽 can phosphorylate enough 𝜏, then we see a
ignificant deterioration due to 𝜏. Conversely, if it cannot, then we see
ery little results due to 𝜏. This implies that the 𝜏 and A 𝛽 interaction
ay play a major role in the disease as the additional phosphorylation
f 𝜏 by A 𝛽 could drive the pathology depending on its nature. 
We believe that the above described numerical results and the sen-
itivity analysis of some of the more significant parameters validate the
implified model which we have presented. We therefore see the model























































































































s a good starting point for the development of more realistic mod-
ls and their simulation in 3D. Among other things, we mention that
he complexity of the brain should be taken into account, including an
natomically correct picture of the neural bundles (that also give rise to
nisotropic diffusion), and that the CFS clearing system should be mod-
lled, including the possible role of the so-called glymphatic system.
he latter topic is particularly challenging and complex, and obviously
annot be described by a single parameter such as our 𝛽. 
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